STOCK TITAN
  1. Home
  2. Sec-filings
  3. HROW
  4. [8-K] Harrow, Inc. Reports Material Event

[8-K] Harrow, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock HROW logo
Harrow Health Inc

NASDAQ:HROW

HROW Rankings

#2437 Ranked by Market Cap
N/A Ranked by Dividends

HROW Latest News

Aug 11, 2025
Harrow Announces Second-Quarter 2025 Financial Results
Aug 6, 2025
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference
Jul 29, 2025
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025
Jul 17, 2025
Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States
Jul 17, 2025
Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States

HROW Latest SEC Filings

Aug 25, 2025
[8-K] Harrow, Inc. Reports Material Event
Aug 11, 2025
[10-Q] Harrow, Inc. Quarterly Earnings Report
Jul 23, 2025
[Form 4] Harrow, Inc. Insider Trading Activity
Jul 1, 2025
[Form 4] Harrow, Inc. Insider Trading Activity
Jul 1, 2025
[Form 4] Harrow, Inc. Insider Trading Activity

HROW Stock Data

1.34B
31.18M
15.72%
57.4%
12.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
NASHVILLE